• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtech M&A report: Quality beats quantity in 2012, with more activity ahead

Medtech M&A report: Quality beats quantity in 2012, with more activity ahead

March 27, 2013 By Arezu Sarvestani

up and down illustration

The medical device sector posted some strong merger & acquisition figures in 2012, and the year ahead is looking bright as well, according to a report from analysts at PricewaterhouseCoopers.

Although deal quantity dropped slightly year-over-year, the value of the medtech M&A market gained significantly, driven primarily by the $21.3 billion Johnson & Johnson (NYSE:JNJ) buyout of Synthes, which closed in July 2012.

The total number of deals dropped from 52 in 2011 to 50 in 2012, but deal value increased from $24.6 billion to $36.4 billion, according to the report. With healthcare reforms causing industry-wide shifts in strategy, analysts expect M&A activity to increase further in 2013.

"Despite a slowdown during the fourth quarter, the medical device segment saw the greatest gains during 2012 in terms of deal value," the analysts reported. "In the medical device sector, as companies have sought to unlock the value of non-core businesses and assets, others have sought to achieve growth by entering new markets and diversifying their product offerings."

Last year was a tough one for the lifesciences sector and deals withered slightly from Q3 to Q4 amid concerns in the U.S. and abroad.

"Domestically, uncertainty related to the presidential election and the potential impact of the “fiscal cliff” hindered transactions during 2012," according to the report. "Globally, the Eurozone debt crisis, a stalled global economic recovery, persistent weakness in the labor markets, disappointing economic growth in the BRIC nations (Brazil, Russia, India, and China) during the first half of 2012, and ongoing instability in the Middle East cooled M&A activity."

Nevertheless, things are looking good for 2013 and PwC analysts predicted an uptick in deals.

"With the implementation of the Patient Protection & Affordable Care Act in the United States and its sweeping reforms reshaping business models, we expect M&A activity to increase across segments in 2013," they noted.

One place to look for such activity may be in the so-called "frontier market" countries: Mexico, Turkey, Indonesia, and African countries.

PwC analysts expect that more buyers will turn to the frontier market as assets become scarce in the ever-popular BRIC nations: Brazil, Russia, India, and China.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Deals Roundup, PricewaterhouseCoopers (PwC)

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy